Common side effects of Vimovo include: increased liver enzymes. Other side effects include: constipation.  See below for a comprehensive list of adverse effects.
As well as its needed effects, esomeprazole / naproxen may cause unwanted side effects that require medical attention. 
If any of the following side effects occur while taking esomeprazole / naproxen, check with your doctor immediately:
Some esomeprazole / naproxen side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:
Naproxen:Postmarketing reports: Anaphylactic reactions, angioneurotic edema, menstrual disorders, pyrexia (chills and fever), hearing impairment
Esomeprazole-naproxen was reported to cause fewer NSAID-related upper gastrointestinal adverse events (e.g., duodenal ulcer) (53.3%) compared to enteric coated naproxen taken as monotherapy (70.4%).NSAIDs, including naproxen, have been reported to lead to upper gastrointestinal ulcers and gross bleeding or perforation in approximately 1% of patient treated for 3 to 6 months, and about 2% to 4% of patients treated for one year.
Esomeprazole-naproxen:Very common (10% or more): Gastritis erosive (up to 38%), dyspepsia (up to 27%), gastritis (up to 17%)Common (1% to 10%): Diarrhea, gastric ulcer, upper abdominal pain, nausea, hiatus hernia, abdominal distension, flatulence, esophagitis, constipation, abdominal pain, duodenitis, erosive duodenitis, lower abdominal pain, hemorrhagic gastritis, gastroesophageal reflux disease, duodenal ulcer, erosive esophagitisPostmarketing reports: HematocheziaEsomeprazole:Postmarketing reports: Pancreatitis; stomatitis; microscopic colitis, GI candidiasis, Clostridium difficile associated diarrheaUncommon (0.1% to 1%): Dyspepsia, dysphagia, dysplasia GI, epigastric pain, eructation, esophageal disorder, gastroenteritis, GI hemorrhage, GI symptoms not otherwise specified, hiccup, melena, mouth disorder, pharynx disorder, rectal disorder, serum gastrin increased, tongue disorder, tongue edema, ulcerative stomatitis, vomiting, abdomen enlarged, Clostridium difficile associated diarrheaNaproxen:Common (1% to 10%): Heartburn, nausea, dyspepsia, stomatitisUncommon (0.1% to 1%): Pancreatitis, melenaPostmarketing reports: Inflammation, bleeding (sometimes fatal, particularly in the elderly), ulceration, and obstruction of the upper or lower gastrointestinal tract, esophagitis, stomatitis, hematemesis, colitis, exacerbation of inflammatory bowel disease (ulcerative colitis, Crohn's disease)
Esomeprazole-naproxen:Common (1% to 10%): Urinary tract infectionEsomeprazole:Uncommon (0.1% to 1%): Vaginitis, cystitis, dysuria, fungal infection, micturition frequency, moniliasis, genital moniliasis
Esomeprazole-naproxen:Common (1% to 10%): Upper respiratory tract infection, bronchitis, sinusitisUncommon (0.1% to 1%): Nasopharyngitis, coughEsomeprazole:Uncommon (0.1% to 1%): Chest pain, substernal chest pain, asthma aggravated, coughing, dyspnea, larynx edema, pharyngitis, rhinitis, sinusitisPostmarketing reports: BronchospasmNaproxen:Common (1% to 10%): DyspneaPostmarketing reports: Eosinophilic pneumonitis, asthma
Esomeprazole-naproxen:Common (1% to 10%): ArthralgiaPostmarketing reports: Joint swelling, muscle spasmsEsomeprazole:Uncommon (0.1% to 1%): Arthralgia, arthritis aggravated, arthropathy, cramps, fibromyalgia syndrome, hernia, polymyalgia rheumatica, back painPostmarketing reports: Muscular weakness, myalgia, bone fractureNaproxen:Postmarketing reports: Myalgia, muscle weakness
Clinical trials and epidemiological data have suggested a small increased risk of arterial thrombotic events (e.g., myocardial infarction or stroke) with the use of "coxibs" or some NSAIDs, especially when used at high doses and for long treatment durations.  Although naproxen doses of 1000 mg per day may be associated with a lower risk than COX-2 selective inhibitors, a small risk cannot be excluded.
Esomeprazole-naproxen:Frequency not reported: Peripheral edema, arrhythmia, palpitations, myocardial infarction, congestive heart failure, hypertension, syncopeEsomeprazole:Uncommon (0.1% to 1%): Flushing, hypertension, tachycardiaNaproxen:Common (1% to 10%): PalpitationsPostmarketing reports: Congestive heart failure, vasculitis, hypertension, pulmonary edema
Esomeprazole-naproxen:Postmarketing reports: Gait disturbancesEsomeprazole:Uncommon (0.1% to 1%): Fatigue, fever, flu-like disorder, generalized edema, , malaise, pain, rigors, earache, tinnitus, vertigo, asthenia, dysmenorrhea, menstrual disorder, hot flushesPostmarketing reports: GI candidiasis, gynecomastiaNaproxen:Common (1% to 10%): Vertigo, tinnitus, hearing disturbances, thirstPostmarketing reports: Angioneurotic edema, menstrual disorders, hearing impairment, infertility, papillitis, malaise, aseptic meningitis
Esomeprazole-naproxen:Postmarketing reports: Renal tubular necrosisEsomeprazole:Uncommon (0.1% to 1%): Abnormal urine, albuminuria, hematuria, polyuria, glycosuria, hyperuricemiaPostmarketing reports: Interstitial nephritisNaproxen:Postmarketing reports: Glomerular nephritis, hematuria, hyperkalemia, interstitial nephritis, nephrotic syndrome, renal disease, renal failure, renal papillary necrosis, raised serum creatinine
Esomeprazole:Uncommon (0.1% to 1%): Acne, angioedema, dermatitis, pruritus, pruritus ani, rash, rash erythematous, rash maculo-papular, skin inflammation, sweating increased, urticaria, facial edemaPostmarketing reports: Alopecia, erythema multiforme, hyperhidrosis, photosensitivity, Stevens-Johnson syndrome, toxic epidermal necrolysis (some fatal)Naproxen:Common (1% to 10%): Pruritus, skin eruptions, ecchymoses, sweating, purpuraUncommon (0.1% to 1%): Skin rashesPostmarketing reports: Alopecia, urticaria, skin rashes, toxic epidermal necrolysis, erythema multiforme, erythema nodosum, fixed drug eruption, lichen planus, pustular reaction, systemic lupus erythematosus, bullous reactions, including Stevens-Johnson syndrome, photosensitive dermatitis, photosensitivity reactions, including rare cases resembling porphyria cutanea tarda (pseudoporphyria) or epidermolysis bullosa
Esomeprazole:Uncommon (0.1% to 1%): Goiter
Esomeprazole:Uncommon (0.1% to 1%): Anemia, anemia hypochromic, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopeniaPostmarketing reports: Agranulocytosis, pancytopeniaNaproxen:Uncommon (0.1% to 1%): Thrombocytopenia, agranulocytosisPostmarketing reports: Eosinophilia, leukopenia, thrombocytopenia, agranulocytosis, granulocytopenia, hemolytic anemia, aplastic anemia
Esomeprazole:Uncommon (0.1% to 1%): Bilirubinemia, abnormal hepatic function, SGOT increased, SGPT increasedPostmarketing reports: Hepatic failure, hepatitis with or without jaundiceNaproxen:Uncommon (0.1% to 1%): JaundicePostmarketing reports: Abnormal liver function tests, hepatitis (some cases have been fatal)
Esomeprazole:Uncommon (0.1% to 1%): Allergic reactionPostmarketing reports: Anaphylactic reaction/shock
Esomeprazole:Uncommon (0.1% to 1%): Hyponatremia, increased alkaline phosphatase, vitamin B12 deficiency, weight increase, weight decrease, anorexia, appetite increasedPostmarketing reports: Hypomagnesemia with or without hypocalcemiaNaproxen:Postmarketing reports: Hyperglycemia, hypoglycemia
Esomeprazole:Uncommon (0.1% to 1%): Hypertonia, nervousness, hypoesthesia, impotence, insomnia, migraine, migraine aggravated, paresthesia, somnolence, tremor, taste lossPostmarketing reports: Hepatic encephalopathy, taste disturbanceNaproxen:Common (1% to 10%): Headache, dysgeusia, drowsiness, lightheadednessUncommon (0.1% to 1%): Inability to concentratePostmarketing reports: Cognitive dysfunction, convulsions
Esomeprazole:Uncommon (0.1% to 1%): Visual field defect, conjunctivitis, vision abnormalPostmarketing reports: Blurred visionNaproxen:Common (1% to 10%): Visual disturbancesPostmarketing reports: Corneal opacity, papillitis, retrobulbar optic neuritis, papilledema
Esomeprazole:Uncommon (0.1% to 1%): Sleep disorder, apathy, aggravated depression, confusionPostmarketing reports: Aggression, agitation, depression, hallucinationNaproxen:Postmarketing reports: Depression, dream abnormalities, insomnia
It is possible that some side effects of Vimovo may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
Blistering, peeling or red skin
burning feeling in the chest or stomach
indigestion
loss of appetite
nausea
stomach bloating, cramping, or pain
tenderness in the stomach area
upper abdominal or stomach pain
upset stomach
vomiting
weight loss
Abdominal or stomach discomfort
black, tarry stools
bladder pain
bloating or swelling of the face, arms, hands, lower legs, or feet
bloody or cloudy urine
bloody stools
chest pain
difficult, burning, or painful urination
difficulty with breathing
difficulty with moving
difficulty with swallowing
frequent urge to urinate
full or bloated feeling
heartburn
lower back or side pain
muscle pain or stiffness
pain in the joints
pain or burning in the throat
pressure in the stomach
rapid weight gain
sores, ulcers, or white spots on the lips or tongue or inside the mouth
swelling of the abdominal or stomach area
tingling of the hands or feet
unusual weight gain or loss
vomiting of blood or material that looks like coffee grounds
Drowsiness
mood or mental changes
muscle spasms (tetany) or twitching
seizures
trembling
unusual tiredness or weakness
vomiting
Acid or sour stomach
belching
diarrhea
Body aches or pain
change in taste
chills
cough
cough producing mucus
difficulty having a bowel movement (stool)
ear congestion
excess air or gas in the stomach or intestines
fever
headache
loss of taste
loss of voice
pain or tenderness around the eyes and cheekbones
passing gas
sneezing
sore throat
stuffy or runny nose